In vitro and in vivo antiproliferative activity of IPCAP, a new pyrazole nucleoside analog

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2623-2630

  Pani, Alessandra ^a   Marongiu, M Elena ^a   Pinna, Elisabetta ^b   Scintu, Franca ^b   Perra, Graziella ^a   De Montis, Antonella ^a   Manfredini, Stefano ^c   La Colla, Paolo ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Sardinian Antiviral Res Consortium   (Italy)

^c UNIVERSITY OF FERRARA   (Italy)

Author keywords

Antitumor chemotherapy; Novel antiproliferative agents

Indexed keywords

CYTARABINE; DOXORUBICIN; FLUOROURACIL; GUANOSINE PHOSPHATE; INOSINE PHOSPHATE; MERCAPTOPURINE; METHOTREXATE; NUCLEOSIDE ANALOG; PACLITAXEL; PYRAZOLE; RIBAVIRIN; TIAZOFURIN; TIOGUANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; CROSS RESISTANCE; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTRAARTICULAR DRUG ADMINISTRATION; KIDNEY CARCINOMA; LYMPHATIC LEUKEMIA; MOUSE; MULTIDRUG RESISTANCE; NASOPHARYNX CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL SURVIVAL; CELLS, CULTURED; CHO CELLS; CRICETINAE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HELA CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; IMP DEHYDROGENASE; KB CELLS; LEUKEMIA L1210; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MOLECULAR STRUCTURE; NUCLEOSIDES; PURINES; PYRAZOLES; PYRIMIDINES; RIBAVIRIN; RIBONUCLEOSIDES; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0031868541     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bellamy WT, Dalton WS, Dorr RT: The clinical relevance of multidrug resistance. Cancer Invest 8: 547-562, 1990.
2. Bhattacharya BK, Robins RK, Revankar GR: A facile synthesis of certain 4- and 4,5-disubstituted 1-ß-D-ribofuranosylpyrazoles. J Heterocyclic Chem 127: 795-783, 1990.
3. Boritzki TJ, Berry DA, Besserer JA, Dancook P, Fry DW, Leopold WR and Jackson RC: Biochemical and antitumor activity of tiazofurin and its selenium analog 2-ß-D-ribofuranosyl-4-selenazole-carboxamide. Biochem Pharmacol 34: 1109-1114, 1985.
4. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurtz EU, Duncan AMV, Deeley RG: Overexpression of transporter gene in multidrug-resistant human cancer cell line. Science 258: 1650-1654, 1992.
5. Cooney DA, Jayaram HN, Gebeyehu G, Betts CR, Kelley JA, Marquez VE And Johns DG: The conversion of 2-ß-D-ribofuranosyl-thiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase inhibitory properties. Biochem Pharmacol 31: 2133-2136, 1982.
6. Denizot F and Lang R: Rapid colorimetric assay for cell growth and survival. J Immunol Methods 89: 271-277, 1986.
7. Drach JC, Barnett JW, Thomas MA, Smith SH, Shipman C: In: Ribavirin. a broad spectrum antiviral agent. Smith R.A. and Kirkpatrick W,Eds. (Academic Press N.Y.), New York, ppl 19-123, 1980.
8. Ferguson PJ, Fisher MH, Stephenson J, Li D, Zhou B, Cheng Y: Combined modalities of resistance in etoposide-resistant human KB cell lines. Cancer Res 48: 5956-5964, 1988.
9. Gabrielsen B, Phelan MJ, See C, Huggins JW, Kefauver DF, Monath TP, Ussey MA: Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-ß-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride. J Med Chem 35: 3231-38, 1992.
10. Gebeyehu G, Marquez VE, Kelley JA, Cooney DA, Jayaram HN and Johns DG: Synthesis of tiazole-4-carboxamide adenine dinucleotide. A powerfull inhibitor of IMP dehydrogenase. J Med Chem 26: 922-925, 1983.
11. Hartman NR, Ahluwalia GS, Cooney DA, Mitsuya H, Kageyama S, Fridland A, Broder S, Johns DG: Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleotides 2'-3'-dideoxyadenosine and 2'-3'-dideoxyinosine. Molecular Pharmacol 40: 118-124, 1991.
12. Jayaram HN, Ahluwalia GS, Dion RL, Gebeyehu G, Marquez VE, Kelley JA, Robins RK: Conversion of 2-ß-D-ribofuranosyl-selenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase inhibitory properties. Biochem Pharmacol 32: 2633-2636, 1983.
13. La Colla P, Manfredini S, Simoni D, Baraldi PG, Pani A: Pyrazole-related derivatives endowed with antitumor and antiviral activities, proced-ures for their preparation, pharmaceutical formulations containing them and intermediates of this process. Patent Appln N PCT/EP96/02485, 1996.
14. Liliemark J, Pettersson B and Peterson C: On the modulation of of 6-mercaptopurine by methotrexate in murine WEI-3b leukemia cells in vitro. Leukemia Res 16: 275-280, 1992.
15. Lui MS, Faderan MA, Liepnieks JJ, Natsumeda Y, Olah E, Jayaram HN: Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-ß-D-ribofuranosyl-thiazole-4-carboxamide). J Biol Chem 259: 5078-82, 1984.
16. Manfredini S, Bazzanini R, Baraldi PG, Guarneri M, Simoni D, Marongiu ME, Pani A, Tramontano E, La Colla P: Pyrazole-related nucleosides. Synthesis and antiviral / antitumor activity of some substituted pyrazole and pyrazolo(4,3-d)-1,2,3-triazin-4-one nucleosides. J Med Chem 35: 917-924, 1992.
17. Manfredini S, Bazzanini R, Baraldi PG, Simoni D, Vertuani S, Pani A, Pinna E, Scintu F, Lichino D, La Colla P: Design, synthesis and antiproliferative activity of methyl 4-iodo-1-ß-D-ribofuranosyl-pyrazole-3-carboxylate and related compounds. Bioorg and Med Chem Lett 6: 1279-1284, 1996.
18. Moorhead RA, Armstrong SG, Wilson BC, Singh G: Cross-resistance to cisplatin in cells resistant to photofrin-mediated photodinamic therapy. Cancer Res 54: 2556-2559, 1994.
19. Natsumeda Y, Yamada Y, Yamaji Y, Weber G: Synergistic cytotoxic effect of tiazofurin and ribavirin in hepatoma cells. Biochem Biophys Res Commun 153: 321-327, 1988.
20. Nooter K, Herweijer H: Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63: 663-669, 1991 .
21. Pani A, Manfredini S, Pinna E, Scintu F, Pisano L, Lichino D, La Colla P: A pyrazole-related nucleoside with potent and selective antitumor activity, in vitro. Personal communication, AACR Meeting, Toronto, Canada, 1995.
22. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J, De Clercq E: Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20, 309-321, 1988 .
23. Poupon R, Sefarty L: Prevention and treatment of hepatitis C. Bull Acad Natl Med 180: 1279-1289, 1996.
24. Schuurhuis GJ, Broxterman HJ, Cervantes A, Van Heijningen THM, De Lange JHM, Baak JPA, Pinedo HM, Lankelma J: Quantitative determination of factors contributing to doxorubicin resistance in multidrug resistant cell. JNatl Cancer Inst 81: 1887-1892, 1989.
25. Sokoloski J: A, Blair OC, Sartorelli AC: Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase. Cancer Res 46: 2314-2319, 1986.
26. Srivastava PC, Robins RK: Synthesis and antitumor activity of 2-ß-D-ribofuranosyl-selenazole-4-carboxamide and related derivatives. J Med Chem 26: 445-451, 1983.
27. Streeter DG, Witkowski JT, Khare GP, Sidwell RW, Bauer RJ, Robins RK, Simon LN Mechanism of action of 1-ß-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole), a new broad-spectrum antiviral agent. Proc. Nall. Acad. Sci. USA 70: 1174-1178, 1973.
28. Suhnel J: Evaluation of synergism or antagonism for the combined actionofantiviralagents. Antiviral Res. 13: 23-40, 1990. 30
29. Tricot G, Jayaram HN, Weber G: Tiazofurin. Biological effects and clinical uses. Int J Cell Cloning 8: 161-170, 1990.
30. Vogt MW, Hartshorn KL, Furman PA, Chou TC, Fyfe JA, Coleman LA, Crumpacker C, Schooley RT, Hirsh MS: Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science 235: 1376-1379, 1987.
31. Weber G: Biochemical strategy of cancer cells and the design of chemotherapy. GHA Clowes Memorial Lecture. Cancer Res 43: 3466-3492, 1983.
32. Weber G: IMP dehydrogenase and GTP as targets in human leukemia treatment. In: Harkness RA, editor. Purine and pyrimidine metabolism in man. VII. Part B. New York: Plenum Press, pp 287-292, 1991.
33. Weber G, Hata Y, And Prajda N: Role of differentiation induction in action of purine antimetabolites. Pharmacy World and Sci 16: 77-83, 1994.